Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL956898 | 0.98 | ELANE (0.46) | ELANEKDM1ADGAT1MTNR1AMTNR1B | |
| SCHEMBL2223556 | 0.87 | ELANE (0.52) | ELANEKDM1ADGAT1HDAC6HDAC1 | |
| SCHEMBL1791670 | 0.80 | ELANE (0.43) | ELANEKDM1AMTNR1AMTNR1BCA2 | |
| SCHEMBL22909379 | 0.79 | ELANE (0.33) | ELANE | |
| SCHEMBL17761153 | 0.77 | ELANE (0.32) | ELANEDGAT1 | |
| SCHEMBL20758462 | 0.77 | ELANE (0.33) | ELANE | |
| SCHEMBL34317 | 0.76 | CA1 (0.36) | CA2TSHRSMN1; SMN2 | |
| SCHEMBL6726719 | 0.76 | MTNR1A (0.40) | ELANEKDM1AMTNR1AMTNR1BCA2 | |
| SCHEMBL17410677 | 0.76 | ELANE (0.51) | ELANEKDM1AMTNR1AMTNR1BCA2 | |
| SCHEMBL24812500 | 0.75 | ELANE (0.43) | ELANEKDM1ACA2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700257-B2 | Photoresist composition and resist pattern formation method by the use thereof | TOKYO OHKA KOGYO CO., LTD. (JP) | 2010-04-20 | — | — | US | disclosed |
| US-7700257-B2 | Photoresist composition and resist pattern formation method by the use thereof | TOKYO OHKA KOGYO CO., LTD. (JP) | 2010-04-20 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7264918-B2 | Resist composition for liquid immersion exposure process and method of forming resist pattern therewith | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-04 | — | — | US | disclosed |
| US-7264918-B2 | Resist composition for liquid immersion exposure process and method of forming resist pattern therewith | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-04 | — | — | US | disclosed |
| US-20070148581-A1 | Photoresist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD (JP) | 2007-06-28 | — | — | US | disclosed |
| US-20070148581-A1 | Photoresist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | ELANE 422/4885KDM1A 113/4885DGAT1 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.